whatshot

ANTH   $1e-06  -99.00% Market Closed

ANTHERA PHARMS INC NEW
show_chart Advanced Chart of ANTH
  • Volume
  • EMA (20)
  • EMA (50)
  • EMA (100)
  • MACD
  • RSI (14)
  • Stochastic
Last Events:

2023-03-29 Trend Power changed from medium strength to strong.

2023-03-29 Trend Power changed from strong to medium strength.

2023-03-28 Trend Power changed from medium strength to strong.

2023-03-28 Trend Power changed from strong to medium strength.

2023-03-27 Trend Power changed from medium strength to strong.

2023-03-27 Trend Power changed from strong to medium strength.

2023-03-26 Trend Power changed from medium strength to strong.

2023-03-26 Trend Power changed from strong to medium strength.

Current temperature: 0.00
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total None Buy None
rsi Sell None None
macd None None None
stoch None None None
ma20 Sell None None
ma50 None None None
ma100 Buy Buy None
ISIN US03674U3005
ceo Mr. John Craig Thompson
Website https://www.anthera.com
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.